Viewing data from:

PREDNISOLONE ACETATE

ANDA

PREDNISOLONE ACETATE | A083032 | EPIC PHARMA LLC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Prednisolone Acetate (2023)

Total Spending

$163.9M

Total Claims

3,527,776

Beneficiaries

2,012,515

Avg Cost/Unit

$6.24

Spending Trend

$138.7M(2019)→$126.4M(2020)→$158.1M(2021)→$163.5M(2022)→$163.9M(2023)

YoY Change:-6.3%

5yr CAGR:-1.8%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain3 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

EUROAPI FRANCEPREDNISOLONE ACETATE

DMF 35291979

HENAN LIHUA PHARMACEUTICAL CO LTDPREDNISOLONE ACETATE USP

DMF 285182014

SYMBIOTEC PHARMALAB PRIVATE LTDPREDNISOLONE ACETATE USP

DMF 327282018

DIOSYNTH BVInactivePREDNISOLONE ACETATE MICRO

DMF 39491980

PFIZER INCInactivePREDNISOLONE ACETATE USP,MICRO & NON MICRO

DMF 55041984

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 25MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.